Prescription drug prices are substantially higher in the United States than in other high-income countries, and as a result, Americans spend more on prescription drugs than residents of other countries. Despite this, the government is not allowed to use its position as the largest purchaser of prescription drugs in the country to bargain for lower prices for patients.
Rep. Lloyd Doggett (D-TX) has introduced the Medicare Negotiation and Competitive Licensing Act (H.R. 1046) to give Medicare the power it needs to effectively negotiate with drug companies and bring drug prices down. Read more here.
Call your member of Congress (MoC) and tell them: co-sponsor H.R. 1046, the Medicare Negotiation and Competitive Licensing Act!